Neuroone Medical Technologies Corporation (NMTC) fundamentals score
and (iv) its OneRF TN ablation system for use in procedures to create radiofrequency lesions for the treatment of pain, or for lesioning
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.7 out of 10, Mixed fundamentals
- Growth: 7.0/10
- Profitability: 3.5/10
- Financial health: 5.6/10
- Earnings quality: 5.9/10
- Valuation: 7.0/10
Scores are calculated from Neuroone Medical Technologies Corporation’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10